Characterizing the Patient Experience of CS/HIPEC Through In-Depth Interviews with Patients: Identification of Key Concepts in the Development of a Patient-Centered Program

  • Valerie A. FrancescuttiEmail author
  • Allison H. Maciver
  • Erika Stewart
  • Nikia Clark
  • Bianca Marrara
  • Frances G. Saad-Harfouche
  • Elisa M. Rodriguez
Peritoneal Surface Malignancy



The cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) procedure is complex, involving lengthy preparation and recovery in a heterogeneous patient group. Understanding the patient experience is essential to improving interactions with health professionals that is critical to recovery.


This study sought to characterize the early recovery and return to quality of life (at 3 and 6–12 months post-surgery, respectively) in patients having undergone CS/HIPEC, through structured interviews.


Two sets of interviews were conducted among 20 CS/HIPEC patients. Interviews were uploaded into QSR NVivo 10 qualitative software (QSR International, Australia) and coded by two study personnel. Interview 1 focused on initial treatment decision making and postoperative hospitalization, while interview 2 focused on recovery, supports, and return to quality of life.


Among the participants, 60% were female and the mean age was 57 years (range 31–71). Diagnoses included disseminated peritoneal adenomucinosis (n = 6), appendiceal adenocarcinoma (n = 4), colorectal adenocarcinoma (n = 6), goblet cell (n = 2), and mesothelioma (n = 2). The first interview identified common themes of perioperative psychosocial isolation, lack of direction, and the importance of an established support system. Patients requested printed and audiovisual materials focused on addressing expectations. The main findings from the second interview captured patient experiences with longer-term complications, as well as surveillance.


Focused interviews with patients recently having undergone CS/HIPEC identified key issues that may be addressed in programs to improve the patient experience. These issues were distinctly different in relation to phase of recovery, and patient-centered programs designed with these factors in mind have the potential to enhance the recovery process.





  1. 1.
    Improving the Patient Experience, The Beryl Institute website. Available at Accessed 30 April 2018.
  2. 2.
    Denkin N, Lincoln Y. Handbook on qualitative research. Thousand Oaks, CA: Sage Publishing Company; 1994.Google Scholar
  3. 3.
    Patton M. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage Publishing Company; 2002.Google Scholar
  4. 4.
    Taylor G. Integrating quantitative and qualitative methods in research. New York: University Press of America; 2004.Google Scholar
  5. 5.
    Sugarbaker P. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.CrossRefGoogle Scholar
  6. 6.
    Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–43.CrossRefGoogle Scholar
  7. 7.
    Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284–92.CrossRefGoogle Scholar
  8. 8.
    Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, et al. Quality-of-life evaluation after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23 Suppl 5:772–783.CrossRefGoogle Scholar
  9. 9.
    Haslinger M, Francescutti V, Attwood K, McCart JA, Fakih M, Kane JM 3rd, et al. A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. Cancer Med. 2013;2(3):334–42.CrossRefGoogle Scholar
  10. 10.
    Eriksson H, Haglund K, Leo Swenne C, Arakelian E. Patients’ experiences of postoperative health related to cytoreductive surgery and hyperthermic intraoperative chemotherapy. J Clin Nurs. 2014;23(1–2):201–10.CrossRefGoogle Scholar
  11. 11.
    Leo Swenne C, Cederholm K, Gustafsson M, Arakelian E. Postoperative health and patients’ experiences of efficiency and quality of care after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, two to six months after surgery. Eur J Oncol Nurs. 2015;19:191–197.CrossRefGoogle Scholar
  12. 12.
    Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM 3rd, Francescutti VA. Current delivery of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery (CS/HIPEC) and perioperative practices: an international survey of high-volume surgeons. Ann Surg Oncol. 2017;24(4):923–930.CrossRefGoogle Scholar
  13. 13.
    Werner BC, Wong AC, Chang B, Craig EV, Dines DM, Warren RF, et al. Depression and patient-reported outcomes following total shoulder arthroplasty. J Bone Joint Surg Am. 2017;99(8):688–695.CrossRefGoogle Scholar
  14. 14.
    Koorevaar RC, van’t Riet E, Gerritsen MJ, Madden K, Bulstra SK. The influence of preoperative and postoperative psychological symptoms of clinical outcome after shoulder surgery: a prospective longitudinal cohort study. PLoS ONE. 2016;11(11):e0166555.CrossRefGoogle Scholar
  15. 15.
    Stenberg U, Cvancarova M, Ekstedt M, Olsson M, Ruland C. Family caregiver of cancer patients: perceived burden and symptoms during the early phases of cancer treatment. Soc Work Health Care. 2014;53(3):289–309.CrossRefGoogle Scholar
  16. 16.
    Hung HC, Tsai MC, Chen SC, Liao CT, Chen YR, Liu JF. Change and predictors of social support in caregivers or newly diagnosed oral cavity cancer patients during the first 3 months after discharge. Cancer Nurs. 2013;36(6): E17–24.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Valerie A. Francescutti
    • 1
    Email author
  • Allison H. Maciver
    • 2
  • Erika Stewart
    • 3
  • Nikia Clark
    • 4
  • Bianca Marrara
    • 5
  • Frances G. Saad-Harfouche
    • 4
  • Elisa M. Rodriguez
    • 4
  1. 1.Department of SurgeryHamilton Health Sciences and McMaster UniversityHamiltonCanada
  2. 2.Department of Surgery, London Regional Cancer ProgramWestern UniversityLondonCanada
  3. 3.Department of Surgical OncologyRoswell Park Comprehensive Cancer CenterBuffaloUSA
  4. 4.Department of Cancer Prevention and ControlRoswell Park Comprehensive Cancer CenterBuffaloUSA
  5. 5.School of Public Health and Health ProfessionsState University of New York at BuffaloBuffaloUSA

Personalised recommendations